New drug combo aims to knock out stubborn lung bug
NCT ID NCT07084402
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests whether adding the antibiotic contezolid to the usual three-drug regimen can better reduce bacteria in the sputum of adults with Mycobacterium avium complex (MAC) lung disease. About 188 participants will receive either the standard treatment alone or with contezolid for six months. Researchers will track how quickly the bacteria clear and monitor for side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
contezolid
What this could lead to
If it works, adding contezolid to standard drugs could help clear the lung infection faster and more effectively for people with MAC pulmonary disease.
What could go wrong
This is a Phase 4 trial, but it's still early for this specific combination. The benefit may be small, and contezolid could cause side effects like any antibiotic. Results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYCOBACTERIUM AVIUM COMPLEX PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Chest Hospital, Capital Medical University
ACTIVE_NOT_RECRUITINGBeijing, Beijing Municipality, China
-
China-Japan Friendship Hospital
RECRUITINGBeijing, Beijing Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Jiangxi Provincial Chest Hospital
RECRUITINGNanchang, Jiangxi, China
Contact Phone: •••-•••-••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.